
Primary Melanoma of the Lung Treated with Surgery, Dabrafenib and Trametinib
Author(s) -
Landgraf Layla G.,
Malias Mark A.,
Patterson Stephen J.
Publication year - 2020
Publication title -
case reports in oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.365
H-Index - 19
ISSN - 1662-6575
DOI - 10.1159/000508093
Subject(s) - case report
This is a case report on a 69-year-old woman who was diagnosed with malignant melanoma presenting in the lung. A complete staging workup was performed by her oncologist, with no skin lesion identified as a primary. CT-guided needle biopsy of the lung nodule was completed, with pathology revealing atypical cells consistent with malignant melanoma. Following full body examination by the cutaneous oncologist, a robotic wedge resection and lymph node dissection accompanied by bronchoscopy were performed. Molecular testing (Caris Life Sciences) of the surgical tumor specimen revealed pathological BRAF DNA mutation in exon 15 / p.V600K . The patient was initially treated with nivolumab, then treated with a combination of dabrafenib and trametinib at recurrence.